15 Best European AI Stocks According to Morgan Stanley

10. Roche Holding AG (OTC:RHHVF)

Number of Hedge Fund Holders: N/A  

Roche Holding AG (OTC:RHHVF) is a Swiss firm that engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. Earlier this year, the company announced that it had entered into a partnership with PathAI, a biotech firm focused on AI, to develop AI-enabled digital pathology algorithms in the companion diagnostics space. Under the terms of the deal, the algorithms developed under this agreement by the companies will be deployed using the Digital Pathology solution marketed by the Swiss drugmaker to clients across Europe.

Last year, Roche Holding AG (OTC:RHHVF) partnered with an Israeli firm called Medial EarlySign to help find patients for a new cancer drug that had shown improved results when tested against standard therapies. The drug, given after surgery to remove lung tumors, decreased the risk of either cancer recurrence or death by 76% compared with standard chemotherapy. AI would help the firm identify patients of this disease, only found in 5% of those with lung tumors, early on and treat accordingly.